Treats non-melanoma skin cancers, keloids and superficial lesions
Will begin collaboration with the launch of the OSF HealthCare Cancer Institute
Acquired Varian for $16.4 billion in early 2021
By comparison, investment in 2018 dropped 62 percent
Supporting proton utilization for three indications
Treating up to 16 patients daily with Pluvicto and other radiopharmaceuticals
Has 32 multidisciplinary rooms, 24 private infusion rooms
From the October issue of HCB News magazine
Making shielded environments less intimidating and more conducive to workflow
Q&A with ASTRO president Dr. Laura Dawson
Will treat more than 3 million Indians with cancer, and other SE Asian populations
With 4-D CT, Colorado Cancer Center is saving money and improving outcomes
New study raises concerns regarding financial motivation
Treatment for neuroendocrine tumors
Promising research points to faster, safer imaging at SIIM
